期刊文献+

超声造影定量诊断肝纤维化 被引量:3

Quantitative diagnostic value of contrast enhanced ultrasound of liver fibrosis
下载PDF
导出
摘要 目的探讨CEUS定量诊断肝纤维化的可行性及意义。方法对肝纤维化组118例及对照组27例患者行CEUS检查,应用时间-强度曲线记录造影剂到达肝动脉、肝静脉、门静脉及肝实质的时间及达峰值时间,分析不同分期肝纤维化的灌注规律。结果在不同分期肝纤维化患者中,造影剂到达肝动脉时间、达峰值时间及门静脉达峰值时间的差异无统计学意义(P均>0.05);S1~S4期患者门静脉到达时间均长于S0(P均<0.05);S3及S4期患者肝静脉到达时间显著短于S0期(P均<0.05);S4期患者肝实质达峰值时间显著早于S0期(P<0.05)。应用ROC曲线,以肝静脉到达时间≤23s为界值,CEUS诊断肝硬化(S4)的敏感度为79.0%,特异度为85.2%;以肝实质达峰值时间≤27s为界值,诊断肝硬化的敏感度为55.6%,特异度为100%。结论 CEUS技术有助于定量诊断肝纤维化,并有望对肝硬化前期做出诊断。 Objective To explore the quantitative diagnostic value of CEUS of liver fibrosis. Methods Totally 145 pa- tients underwent CEUS, including 118 patients with hepatitis history ( liver fibrosis group) and 27 patients without chronic hepatitis history and clinical signs (control group). Liver samples were achieved with biopsy or operation. The arrival time and peak time of hepatic artery, hepatic vein, portal vein and liver parenchyma were observed by using time intensity curves, and the relationship of fibrosis stages and the perfusion times among each stage was investigated. Results The ar- rival time and peak time of hepatic artery and the peak time of portal vein were not significantly different in different fibrosis stage. The arrival time of portal vein in S1--S4 was longer than SO (all P〈0.05). The arrival time of hepatic vein in S3 and S4 were significantly shorter than SO (both P〈0.05). The peak enhancement time of liver parenchyma in S4 was earli- er than SO (P〈0.05). ROC analysis showed when the arrival time of hepatic yein 423 s, the sensitivity and specificity of CEUS in diagnosis of liver cirrhosis (S4) was 79.0% and 85.2%, for the peak time of liver parenchyma ≤27 s, the value of sensitivity and specificity was 55.6% and 100%, respectively. Conclusion CEUS has potential as non-invasive diagnos- tic modality for cirrhosis, and may be useful to diagnosis of pre-cirrhosis.
出处 《中国医学影像技术》 CSCD 北大核心 2012年第12期2206-2210,共5页 Chinese Journal of Medical Imaging Technology
基金 北京大学肿瘤医院院内基金(04-17)
关键词 超声检查 造影剂 肝硬化 Ultrasonography Contrast media Liver cirrhosis
  • 相关文献

参考文献11

  • 1Khan KN, Yamasaki M, Yamasaki K, et al. Proposed abdominal sonographic staging to predict severity of liver diseases: Analysis with peritoneoscopy and histology. Dig Dis Sci, 2000,45(3) :554- 564.
  • 2Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diag- nosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet, 1999,353(9164):1579-1583.
  • 3尹珊珊,严昆,戴莹,武金玉,陈敏华.实时灰阶超声造影对肝硬化定量诊断的初步探讨[J].中国医学影像技术,2004,20(5):731-733. 被引量:25
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 5Lim AK, Patel N, Eckersley RJ, et al. Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol, 2005,184(6) : 1848-1853.
  • 6丁红,李娜,林希元,范培丽,王文平,王吉耀.超声造影评估肝纤维化程度的可行性及定量参数筛选[J].复旦学报(医学版),2010,37(3):265-268. 被引量:21
  • 7Sugimoto H, Kaneko T, Hirota M, et al. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intra- hepatic hemodynamic changes accompanying cirrhosis. J Hepatol, 2002,37(5) : 578-583,.
  • 8Gaiani S, Serra C, Piscaglia F, et al. Effect of levovist on splanchnic hemodynamics in cirrhotic patients. Ultrasound MedBiol, 2003,29(5):643 648.
  • 9Ridolfi F, Abbattista T, Marini F, et al. Contrast-enhanced ul trasound to evaluate the severity of chronic hepatitis C. Dig Live Dis, 2007,39(10):929-935.
  • 10Abhattista T, Ridolfi F, Ciabattoni E, et al. diagnosis of liver cirrhosis hy transit time analysis at contrast-enhanced ultra-sonography. Radiol Med, 2008, 113(6) :860-874.

二级参考文献17

  • 1王本刚,徐智章,丁红,章建全.基于DICOM标准的超声造影分析系统[J].上海医学影像,2007,16(2):169-171. 被引量:22
  • 2[1]Gaiani S,Gramantieri L,Venturoli N,et al.What is the criterion of differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy[J].J Hepatol,1997,27(6):979-985.
  • 3[2]Khan KN,Yamasaki M,Yamasaki K,et al.Proposed abdominal sonographic staging to predict severity of liver diseases:analysis with peritoneoscopy and histology[J].Dig Dis Sci,2000,45(3):554-564.
  • 4[3]Zoli M,Magalotti D,Bianchi G,et al.Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis[J].J Hepatol,1995,23(2):129-134.
  • 5[4]Albrecht T,Blomley MJ,Cosgrove DO,et al.Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent[J].Lancet,1999,353(9164):1579-1583.
  • 6[5]Sanford NL,Walsh P,Matis C,et al.Is ultrasonography useful in the assessment of diffuse parenchymal liver disease[J]? Gastroenterology,1985,89(1):186-191.
  • 7[6]Vilgrain V.Ultrasound of diffuse liver disease and portal hypertension[J].Eur Radiol,2001,11(9):1563-1577.
  • 8[8]Numata K,Tanaka K,Kiba T,et al.Contrast-enhanced,wide-band harmonic gray scale imaging of hepatocellular carcinoma:correlation with helical computed tomographic findings[J].J Ultrasound Med,2001,20(2):89-98.
  • 9[9]Sugimoto H,Kaneko T,Hirota M,et al.Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis[J].J Hepatol,2002,37(5):578-583.
  • 10[10]Gaiani S,Serra C,Piscaglia F,et al.Effect of Levovist on splanchnic hemodynamics in cirrhotic patients[J].Ultrasound Med Biol,2003,29(5):643-648.

共引文献14050

同被引文献35

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部